logo

Project Code

02-302-2552

Research team

Researchers

Co - Researcher

Dr.Viroj Tangcharoensathien

Chutima Akaleephan

Nakor Premsri

Chawetsan Namwat

Project Details

Project Status

Completed - 100%

Viewer: 964

Publish date8 December 2011 04:33

Project Summary

A cost-utility analysis was performed to estimate the costs and quality adjusted life year (QALY) of HIV prevention program compared to only existing programs. This analysis focused on both the general population and high risk populations. This study found that the incremental cost effectiveness ratio of HIV vaccination was most sensitive to change in risk behaviors at the post-vaccination period. If postvaccination risk behavior remained unchanged, HIV vaccination for high risk populations would be more cost-effective than for the general population.

Documents

Activity